Microcystins (MCs) are toxic merabolites producecl by several cyanobacterial (blue green algae) species found in almost every environment worldwide. They are cyclic heptapeptides consisting of >80 structural congeners with a size between 909-1115 Da (Sivonen and jones, 1999; Spoof, 2005; Zurawell et aL, 2005; Humpage, 20[) 
8).
a trait also used for their nomenclature (Carmichael et aI., 1988) , and secondarily in slight modifications of the amino acids of the cyclic heptapeptide backbone, e.g. absence or additional methyl groups, ete.
MCs are very potent inhibitors [or serineithreonine-specific protein phosphatases (PPs), especially I'l'l and pP2A, as well as 1'1'3-1'1'6, whereas no inhibition of pp2B, PP2C and 1'1'7 was observed (MacKintosh, 1993; Honkanen et aI., 1994; Runnegar et aI., 1995; Toivola et al.,1997; Hastie et aI., 2005) . MC-mediated inhibition of PPs results in hyperpl1osphorylation of numerous phosphate-regulated enzymes and subsequent deregulation of fundamental cellular processes, e,g. disruption of the cytoskeleton (Eriksson et aI., 1990; Yoshizawa et aI., 1990; Ohta et aI., 1992; Wickstrom et aI., 1995; Batista et aI., 2003) . The inhibitory capacity of single MC congeners on pPI and PP2a in vitro is comparable, with IC 50 values in the sub-and lower nanomolar range (Robillot and Hennion, 2[)04; Hoeger et aI., 2007; Monks et aI., 20(7) . suggesting a highly conserved molecular mode of action, Surprisingly, the LD50 values (mice, Lp.) for various MC congeners differ distinctly from one another, as summarized in
Their general structure is cyclo( -D-Ala l-L-X 2 -D-erythro-["-methy-
IAsp3-I.-Z4-Adda5-D-Glu6-N-methyldehydro-Ala7) in which Adda stands for the unique D-amino acid 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid and X and Z [or variable I.-amino acid residues (Botes et aI., 1984 (Botes et aI., , 1985 Hinehart et aI., 1988 Hinehart et aI., , 1994 . The MC congeners differ primarily in these two I.-amino acids, Sivonen and Jones (J999) . However, the oven: discrepancy belween similar in vitro pp inhibition (in situ toxicodynamics) and differing in vivo (Lp.) acute toxicity remains unresolved to date. This led to the initial hypothesis of this study that the toxicity of single MCs is primarily a result of their individual toxicokinetics (absorption and distribution) and not due to differences in toxicodynamics (PP-inhibition).
Indeed, as a result of their structure and amino acid composition, MCs are rather hydrophilic and spatially large molecules. Hence, they apparently are incapable of crossing cell membranes via passive diffusion, but rather require active transport via specific transporters, as suggested by indirect experiments (Erikssoll et aL, 1990a; Runnegar et aI., 1995a) employing substrates for and inhibitors of organic anion transporting polypeptides (OATPs). Fischer et aL (2005) demonstrated that human OATPIBl, OATPIB3, OATPIA2 and rat Oatpl b2 [human: OATPs/SLCOs; animals: Oatps/Slcos; (protein name/gene symbol) (Hagenbuch and Meier, 2004) J are capable of transporting [3HJ-dihydromicrocystin-LR. The active uptake of native non-Iabeled MCLR and other MC congeners via OATPs was confirmed by using cells stably expressing OATPIBl and OATP1B3, respectively (Komatsll et aI., 2007; Monks et aI., 20(7) . Recently, Lu et a!. (2008) demonstrated a strongly decreased MCLR-mediated hepatotoxicity in Oatp] b2-null mice suggesting this knock-out model as useful for interpreting the importance of this transporter's human orthologs OATPIBI and OATP1B3 in the distribution of MCs and their ensuing potential toxicity. Indeed, members of the multi specific OArp family can be detected in nearly all tissues of humans, rodents and other animals. They play an important role in the absorption, distribution and excretion of numerous xenobiotica (Hagenbuch and Meier, 2003; 2(04) . While the human MCs-transporting OATPIB1 and OATPIB3, are exclusively located at the sinusoidal (basolateral) membrane of hepatocytes, OATP] A2 is located in the membrane of liver and kidney cells, as well as the blood-brain barrier (Meier and Stieger, 2002; Hagenbuch and Meier. 2003; van Montfoort et aI., 2003; Hagenbuch and Meter, 2004; Mikkaichi et aL. 2(04) .
Therefore, llsing HEK293 cells stably expressing liver-specific OATPIB1 and OATPIB3 and primary human hepatocytes, this study determined whether the toxicity of single MCs (MCLR (L-leucine, Larginine), MCRR (L-arginine, L-arginine), MCLW (L-leucine, L-tryptophan) and MCLF (L-leucine, L-phenylalanine») is a result of their individual toxicokinetics. To determine the toxicodynamic characteristics (PP inhibition) of the four MC congeners, colorimetric protein phosphatase inhibition assays with recombinant PP1 and PP2A and homogenates of OAfPIBl and -JB3 expressing HEK293 cells were employed. Okadaic acid (OA), known to inhibit serine/threoninespecific protein phosphatases with similar potency as MCs (MacKintosh, 1993; Honkanen et aL, 1994; Toivola et aL, J 997; Hastie eta!., 2(05) ,yet capable of transport independent trans-membrane diffusion, was employed as a toxicodynamic and -kinetic positive controL
Material and methods

Glemicals and reagents.
All chemicals were of the highest analytical grade commercially available. Standards of MCLR, MCRR, MCLW and MCLF were obtained from Alexis (Switzerland) and dissolved in 75% MeOH. The concentrations of the stock and the working solutions were confirmed photometrically using the molar absorption coefficient of MCLR and MCRR (39800 mol 1-1 cm-I) published by Harada et al. (1990) . Although this is the molar absorption coefficient for MCLR/-RR dissolved in 100% MeOH, it turned out to be applicable for 75% MeOH as well (Meriluoto et aL, 2004; Meriluoto and Spoof, 20(5) . In the absence of published molar absorption coefficients for MCLW and MCLF, the molar absorption coefficient for MCLR and MCRR was applied. Additionally, concentrations were confirmed by HPLC-DAD analysis according to Lawton et aL (1994) . Okadaic acid (OA) (Sigma, Germany) was dissolved in 100% H 2 0, diluted to the stock and working concentrations according to the manufacturer's specifications. All toxins were sterile filtrated using a 0.22 fill1 filter (Millex-GV, sterile; Millipore, Ireland).
Cell systems_ Human primary hepatocytes were isolated in agreement with the ethical review board and after the patients' written consent by a standard operating procedure and cultured as described previously (Nussler et aL, 20(9) . All four donors were females. Donor 1: partial liver resection due to cholangiocardnoma (CCC), born 1961; donor 2: partial liver resection due to liver metastasis of primary mamma carcinoma, born 1965; donor 3: partial liver resection due to liver metastasis of primary colorectal carcinoma, born 1962; and donor 4: partial liver resection due to liver metasrasis of primary colorectal carcinoma, born 1934.
Human embryonic kidney cells (HEK293) stably transfected with recombinant human organic anion transporting polypeptides 1 Bl (I-IEK293-0ATPl Bl) and 1 B3 (I'IEK293-0ATP1 B3), or control vector (HEK293-CV) were kindly provided by Prof. Dietrich Keppler (Division of Tumor Biochemistry, German Cancer Research Centre, Heidelberg, Germany). HEK293 cells were cultured in minimal essential medium (MEM) with Earle's Salts and L-Glutamine supplemented with 10% FBS, lOO units/ml penicillin, 100 Illg/ml streptomycin and 400 ~tg/ml G418-sulphate at 37°C and 5% CO 2 , All cell culture media and supplements were purchased from PM Laboratories GmbI-l (Austria).
Toxin exposure. Passages 3-8 of transfected HEK293 cells were used for toxin exposure experiments. HEK293 cells were seeded in 96-well plates in MEM (supplemented as described above) at a density of 3 X]05 cells/ml and 200 pi/well (6x 10 4 cells/well). Prior to seeding, 96-well plates were coated with P01Y-L-lysine (5 mg/ml). After 4-5 h, the medium was decanted and cells incubated in 200 pi MEM (supplemented as described above, albeit with 1% FBS). Cells were incubated with serially diluted toxins (1:3); MCLR and -RR ranging from 5000 nM to 2.29 nM, MCLW and -LF ranging from 200 to 0.09 nM and OA ranging from 93 to 1.15 nM, respectively.
For toxin exposure experiments, human primary hepatocytes of three different donors were used. Primary hepatocytes from donors 1 and 2 were employed to assess donor-specific differences in MCmediated cytotoxicity (see below). Cells were seeded in collagencoated 96-well plates (Price, 1975 ) at a densityof3 x 10 5 cells/ml and 200 pi/well (6x 10 4 cells/well). After arrival, the cells were incubated at 37°C and 5% C02 for 4-5 h. Prior to exposure, the medium was decanted and replaced by 200 pi RPMI 1640 containing lOO units/ml penicillin and 100 mg/ml streptomycin. Cells were incubated with serially diluted toxins (I :3); MCLR and -RR ranging from 5000 to 2.29 nM, MCLW, -LF and OA ranging from 200 (() 0.09 nM. To re-dissolve rvffi-formazan, 100 j.tl solubilization buffer (95% (v/v) isopropanol, 5% (v/v) formic acid) was added to each well. After a minimum ofl5 min careful shaking, absorption was determined at 550 I1m in a microtiter plate reader (Tecan, micro plate reader, infinite M200; Austria).
Co
As positive control (0% survival), cells were incubated with 1~i TWEEN (8 wells/96-well plate). Cells incubated with medium only (16 wells/96-well plate) were taken as negative control (100% survival). The highest MeOH and water concentration in the assay was < 2% and used as solvent control (16 wells/96-well plate). No differences in viability, condition or growth rate could be identified between solvent and negative control (data not shown).
Calorimetric protein phosphatase inhibition (cPPLI\) assay, The assay was carried out with MCLR -RR. -LW, -LF and okadaic acid (OA) in concentrations diluted serially (1 :3) from 600 to 0.03 nM and 400 to 0.02 nM, respectively. MC congener-specific protein phosphatase inhibition in PP1 (rabbit skeletal muscle, recombinant (E. coli), New England Biolabs, USA) and PP2A (isolated from human red blood cells, Promega, USA) were determined as described by Heresztyn and Nicholson (2001) with the following minor modifications: both PP2A and PPl were employed in stock concentrations of 500 units/ml and 2,500 units/ ml, respectively, which resulted in final assay concentrations of 1.5 units/m I for PP2Aand 3units/ml for PP1. P-nitrophenyl phosphate from Acros Organics, USA, was used as substrate for the protein phosphatases. The absorption was measured at 405 nm in a microtiter plate reader (Tecan, microplate reader, infinite M200; Austria).
The assay was further modified when PPs of human primary hepatocytes homogenates (a mixture of donor 1 and 2 hepatocytes) or homogenates of I-lEK293-CV, -OAfPl Bland -OAfP1 B3 were used. After washing three times with PBS, cells were extracted in modified enzyme solution, containing H 2 0 instead of BSA, for 10 min on ice while being re-suspended with a syringe and! or a pipette. Cell extract protein concentration was determined by the method of Bradford (Brad ford, 1976) (Bio-Rad Protein Assay; Bio-Rad, Germany). Briefly, in a preliminary assay, homogenates of human primary hepatocytes, HEK293-0ATPIBl. HE1<293-0ATPIB3 and HEK293-CV were taken through a dilution series with enzyme solution in order to approach tIle higllest protein phosphatase activity applicable which is restricted by the maximal optical density. For the final optimized inhibition assay. 3 !Jghtl of total protein of human primary hepatocytes and 0.4 fIg/pi of (Otal protein of each respective HEK293 transtectant were employed, Homogenates were incubated with the respective inhibitors for 30 min at 37"C. Homogenates of the HEK293 cells were incubated with all four MC congeners and OA using the same concentration ranges as described above. Similarly, homogenates of human primary hepatocytes were incubated with MCLR and OA only and in concentrations diluted serially (1 :3) from 600 to 2.47 nM and 400 to 1.65 nM. respectively, due to limited availability of primary hepatocytes from donors 1 and 2.
Iml111Hloblot detection of PPl and PP2A. Immunoblm detection was carried out as described previollsly (Feufstein et aL, 20(9) using 60 !Jg of total protein of primary hepatocytes from donor 4, as well as with total protein from a mixture of donors 1 and 2 (see Fig, 1S ), Monoclonal mouse antibodies anti-PP1o: (P7607; Sigma, Germany) 11 and anti-PP2A (05-545; Millipore, Germany) were diluted 1 :2000 and 1 :500, respectively. The secondary HRP-Iabeled antibody rabbit antimouse (P0260; DakoCytomation, Germany) was applied in a dilution of 1 :1000. GAPDH served as house-keeping protein control and was detected with a 1 :200 dilution of rabbit polyclonal anti-GAPDH (sc-25778, Santa Cruz Biotechnology Inc., USA). The secondary HRPlabeled antibody goat anti-rabbit (A0545; Sigma, Germany) was applied in a dilution of 1 :160,000.
Immunofluorescence detection of OATPlBl and OATPlB3. Primary human hepatocytes (mixture of donor 1 and 2) were seeded onto collagen-coated cover slips (Price, 1975) in 24-well-plates at a density ofO.5 x 1 0 6 cells/well. HEI<293 cells were seeded on polY-L-lysin coated cover slips (5 mg polY-L-lysin/ml) in6-well-plates at the same density, After three washes with PBS, cells were fixed by incubating with ice-cold Acetone /MeOH (1: 1) for 5 min. Following removal of the fixative, cells were dried on ice for another 5 min and subsequently stored at ~~ 20"C until further treatment. Prior to incubation with the polyclonal primary antibodies, rabbit anti-OAfP1Bl (Konig et al., 2000a) and rabbit anti -OATP1 B3 (Kiinig et aI., 2000b) , both kindly provided by Dietrich Keppler (Division of Tumor Biochemistry, German Cancer Research Centre, Heidelberg, Germany), for I h at room temperature cells were washed three times with PBS for 10 min each. These washing steps were repeated prior to ,U1d again after incubation with the TRITC-Iabeled secondary antibody goat antirabbit IgG (T6T78; Sigma, Germany) in the dark for another hour at room temperature. Finally, cells were washed once with H 2 0, mounted with Fluorescent Mounting Medium (Da1<o, Germany) onto a slide and kept dark at 4"C until visualizing using a con focal laser microscope (LSM 510 META, Zeiss, Germany).
Statistics, Colorimetric PP-inhibition assays and cytotoxicity studies were carried out 2.3 times in duplicates. Mean values and standard deviations were calculated based on the mean values of the replicates (n2. 3). For calculation of the respective R2, [C so values and statistical analysis, GraphPad Prism 5 software was used. Briefly, the respective mean values were log-transformed and normalized. The resulting curves were fitted by nonlinear regression. was employed for the comparison of the EC so values, hill slopes and curves. Significant differences in cytotoxicity of individual microcystin-congener concentrations in comparison to concurrent controls were determined via one-way ANOVA followed by Dunnett's Multiple Comparison Test (p<0.05) .
Co-incubation studies were performed three to seven times in duplicates. The mean values of each duplicate yielded the values for calculation of the standard deviation (112. 3). Significance of effect was determined via one-way ANOVA followed by Tukey's Multiple Comparison Test employed to assess significant differences between all groups (controls and exposures with/without competitor).
Results
Comparable roxicodynamics of dUferent microcystin congeners
The MC congener IC 50 values obtained with PPl A (Table 1 ; Fig. 1 A) suggested a significant, albeit very small, difference in the mean phosphatase inhibiting capacity of the 4 different congeners, MCLR having highest activity followed by -RR, -LW and -I.F, as shown by the non-overlapping 95% confidence intervals of the IC so values of the individual congeners (Table 1) . In contrast, the four different congeners did not demonstrate significantly different PP-inhibiting capabilities in recombinant PP2A (Table 1 ; Fig. ] B) , However, all four MC congeners inhibited the recombinant PP1 and PP2A halt~ maximally between 0.9-1.9 nM, suggesting overall a comparable PP-inhibiting capability, thus toxicodynamic property, irrespective of the MC congener and PP employed.
Similarly, no MC congener-dependent differences in PP-inhibition could be observed in the respective homogenates of HEK293-CV, HEK293-0ATP1 Bl, and HEK293-0ATP1B3 ( Figs. 2A-D) , thus corroborating the findings observed in the recombinant PPs. A comparable PP-inhibition curve was obtained with the positive control, OA (Fig. 2E) . Of the total intracellular PP activity (100%) presenr in the homogenates of HEK293 transfectants and primary human hepatocytes (a hepatocyte mixture of donor] and 2), MC congeners were capable of reducing PP activity to approx. 70% and to less than 90%, respectively, thus suggesting a dramatically lower amount of ser/thr PPs in the primary human hepatocytes (Fig. 21') . A limited quantity of ser Ithr PP in the human hepatocytes is also suggested by the fact that no dose-response was obtained. but rather already the smallest concentrations applied already reduced PP activity maximally (to <90% of the total PP activity present).
Above interpretation is supported by I'l'l and PP2A immunoblot analysis in homogenates of primary human hepatocytes and HEK293 transfectants. Whereas. HEK293 transfectants presented with comparable bands of 1'1'1 and Pp2A (supported also by densitometric analysis using the pp:GAPDH density ratio). only faint PPl and marginal pP2A could be detected in the homogenates of the primary human hepatocytes of donor 4 (Fig. 3) . Indeed. densitometric analyses suggested that quantities of PPl and PP2A in the primary hepatocytes of donor 4 were only 3S~b and 8% of the values observed in the HEK293 transfectants (Table IS) .
Microcystin congener-dependent cellular uptake in HEK293-transfectants
The presence ofOATP1Bl and OATP1B3 was confirmed immunocytochemically in plasma membranes of primary human hepato(:ytes (Donor 2; Figs. 4A and B) and HEK293 transfectants (Figs. 4C and D) . However, the immunofluorescence signal appeared to be more intensive in the OATP-transfected HEK293 cells than in the primary human hepatocytes. No cross-reactivity of the 2 OATP-antibodies was observed (data not shown). As expected, no OATP-immunopositive signal was detected in HEK293 cells transfected with the control vector (Figs. 4E and F).
Cells transfected with control vector showed no cytotoxicity irrespective of the MC congener or concentrations employed. whereas the cell-permeant positive control. OA, demonstrated the expected cytotoxicity (Fig. SA) . Indeed, nearly identical dose-response curves were obtained with OA in all HEK293 transfectants (A-C), although the ECso values varied slightly with 9.5 nM (8.2-11.1 nM; R 2 =0.960S) for HEK293-CV. 10.5 nM (9.3-11.7 nM; R 2 =0.9S69) for HEK293-0ATplBl and 7.6 nM (6.2-9.4 nM; R 2 =0.9326) for HEK293-0ATpl B3. In contrast, MC congener-dependent concentration-response curves were observed in OATP1Bl-, as well as OATP1B3-transfected cells (Figs. SB and C) . The ECso values for HEK293-0ATPl Bl ranged from 10.4 nM for MCLW to beyond 5000 nM for MCRR. For HEK293-OATPl B3, the ECso values ranged from 3.7 nM for MCLF to 1267 nM for MCRR (Table 1) . The ECso values of the more hydrophobic MC congeners LW and LF were comparable among the transfectants, whereas the EC 50 values of MCLR and -RR differed distinctly from each other. Although, MCLR gave a comparable dose-response curve in both HEK293-0ATP-transfectants. HEK293-0ATpl Bl cells appeared to be less susceptible to MCs than HEK293-0ATP1B3. Indeed, MCLW and -LF are t<1ken up much more rapidly Ol'with higher affinity (up to 2 orders of magnitude) by HEK293-0ATP1Bl and HEK293-0ATplB3 cells than MCI.R RR at approximately one order of magnitude less efficiently than MCI.R and up to 4 orders of magnitude less efficiently than MCLW and -1.1'. While, MCLR had no effect on HEK293-CV-transfectants, high concentrations ofTC (500 pM) in the absence/presence of MCLR lead to significant but limited cytotoxicity (Fig. 6A). [n contrast, none ofthe HEK293-0ATP transfectants were sensitive to TC cytotoxicity, whereas HEK293-0ATP1Bl were susceptible to 100 !lI' v1 BSP and HEK293-OATP1B3 were susceptible to 100 and 50 I-tM BSP (Figs_ 6C-F), A concentration of 333 I-tM BSP did not reduce viability in either OArp transfectants, albeit the HEK293-0ATPl B3 cells appeared more sensitive toward BSP-mediated cytotoxicity than the OATPl Bl transfectants. MCLR competition experiments with the known OATP substrates TC and BSP demonstrated a reduction of MCI.R cytotoxicity in both HEK293-0ATP-transfectants. However, TC afforded protection from MCLR-mediated cytotoxicity at low concentrations of MCI.R only. BSP, on the other hand. was protective in 5 pIVl MCLR competition incubatiol1s at 100 and 50 I-tM BSP in HEK293-0ATPl Bl (Fig. (0) . while a 5 pM BSP concentration was no longer protective. Similarly. BSP was protective in HEK293-0ATPl B1 at lower MCLR Fig. 4 .lmmt1l1ofiuorcscellCe detectiol1 ofOA"Il'lB 1 in plasma membranes of prim my human hepalocytes of donor 2 (A). HEK293-0ArPIB 1 (C) and HEK293-CV (E) and of OATPlB3 in plasma membranes of primary human hepatocytes (Il), HEK293-0ATP1B3 (D) and HEK293-CV (F), Note the absence of staining in HEK293-CV when stained with OATP1Bl and OATP1 B3 antibody_ concentrations. In contrast, due to the high cytotoxicity of BSI' in I IEK293-0ATPl B3 cells, only the non-cytotoxic 5 pM BSI' concentrations afforded protection from 257.1 nM MClR-mediated cytotoxicity (Fig. 6F) .
Microcystin congener-dependent cellular uptake in primary human Itepatocytes
As observed in the HEK293-transfectants, MC congener-dependent cytotoxicity was observed in the primary hepatocytes of both donors (Fig, 7) , whereby MCLW and -IF were the most, MCLR intermediate, and MCRR the least cytotoxic of the congeners (Tablel ). Differences were observed with regard to the relative sensitivity of the donor 1 and 2 hepatocytes in that hepatocytes of donor 2 were approximately one order of magnitude less sensitive to MCLR -RR and OA (Table 1 Similar to the observations made with HEK293-0ATP transfecrants, no protective effect of TC was found in primary human hepatocytes of donor 3 when co-exposed to 5 pM MCLR (Fig. 8A) . TC itself proved to be cytotoxic lo primary hepatocytes at concentrations ? 166,7 pM. Moreover, BSP at concentrations? 33.3 pM was cytotoxic to primary human hepatocytes (Fig, 8B) Fig. 1 ) and for homogenates of all HEI<293 cells (Fig, 2) . thus corroborating earlier findings by Robillot and Hennion (2004) , Hoeger et aL (2007) and. with the exception of MCRR. by Monks et al. (2007) , A limited supply of primary human hepatocytes from one and the same donor prevented a comparable MC congener comparison as carried out with the I-IE1<293 OATP transfectants. However. a pp inhibition assay with a mixture of homogenates of donors 1 and 2 and MC and OA demonstrated pp inhibition albeit at much lower levels than observed in the HEI<293 cells (Fig. 2F) . possibly suggesting lower amounts of ser/thr-PPs in the primary human hepatocytes. Indeed. MCs and OA maximally reduced total pp activity by approximately 25-35% and IS%. respectively (Figs, 2A-E) in HEK293 cells. In contrast. MC-LR and OA led to a maximum reduction of total pp activity of 10-lS% in the primary human hepatocytes tested (Fig, 2F) . Given that MCs and OA are specific inhibitors of distinct ser /thr-specific PPs. whereas the employed p-nitrophenyl phosphate (pNPP) is substrate for all pPs. these results would suggest that the ratios of ser/thr-PPs to total PP activity were different in the HEK293 and the primary human hepatocytes employed, The latter interpretation is supported by the fact that: 1) Total PP activity of primary human hepatocytes determined by the colorimetric protein phosphatase inhibition assays (cPPIAs) was comparatively low. since 7.5 times more total protein was needed to get a similar pNPP turnover as in the HEK293 cells. suggesting decreased PP activities. 2) Immunoblot detection of PP1 and especially PP2A in bottl cell types revealed distinctly weal<er bands for primary hepatocytes of donor 4 (Fig, 3 ) and of the donor 1 and 2 mixture (see Fig. 1 S) . although equal protein amounts were employed, 3) Densirometric analyses using PP ro GAPDH ratios, suggested that PP] and PP2A levels in primary human hepatocytes of donor 4 were only 3S% and 8%, respectively. of the levels found in HEI<293 transfectants (see Table IS ).
Although the latter may also be due to differences in the protein phosphatase-epitopes in HEI<293 cells and primary hepatocytes. thereby altering primary antibody epitope recognition and binding specificities (Michalski et aL, 2002; Letschert et aL. 2004; Lee et aL. 200S) . the principle finding of the cPPIAs strongly supports the finding that MC congeners have comparable PP inhibiting capacities in human cell lines (HEI<293) as well as in primary human hepatocytes of donors 1 and 2, Thus differences in apical cytotoxicity observed among MC congeners or among cell lines or cell types appear to be primarily driven by the type and expression levels of OATPs. albeit differences in protein phosphatase type and expression levels cannot be ignored.
Since the HEI<293 were originally transfected by subcloning the OATP cDNAs into the expression vector pcDNA3.1 (+) (Kiinig et aL. 2000a (Kiinig et aL. , 2000b , thus being under control of the same promoter (cytomegally virus), it may be assumed that the HEK293 cells were stably expressing comparable levels of recombinant human OATP1Bl/SLCOlBl and OATP1B3/SLCOIB8. The latter assumption was at least qualitatively supported by the immunofluorescence staining for the two OATP transporters (Fig. 4) , thus allowing the assumption that any apical MC congener-induced cytotoxicity is not 
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the result of differences in pp and! or OATP expression among the two HEK293 transfectants. Indeed, the levels of pp expression following densitomelric analyses appeared to be comparable among all HEK293 transfectants (Table 1 S) . MC cytotoxicity was congener-dependent (Table 1; affinities and transporting capacities of the OATP expressed for the respective MCs. The more hydrophobic MC congeners LW and LF elicited the highest effects with similar 48 h EC so values each in the low nanomolar range. Remarkably, MQ.R appeared to be approximately 20 times and 60 times less toxic than MCLW and -LF in OATPl Bl-and OATPI B3-expressing HEK293 cells, respectively. MCRR was the least cytotoxic congener and elicited no effects in HEK293-OATPIBl at all concentrations applied. HEK293-0ATP1B3 were more than 300 times less susceptible to MCRR than to MCLW and MCLF. No cytotoxicity was observed in control vector-transfected HEK293 cells, thus confirming the assumed OATP transport-dependent uptake with ensuing cytotoxicity for all four MC congeners. The latter findings confirmed the general trend observed in earlier cytotoxicity data in HeLa cells transiently transfected with OATPIBl and OATPIB3 (Monks et aI., 2007) , albeit the 72 h ECsos ohtained for MC-LW and -LF in the transiently transfected HeLa cells were in the subnanomolar range. The overt differences in ECsoS obtained with the transiently transfected HeLa when compared to the stably transfected HEK293 cells reported here, most likely are a reflection of (a) different expression levels of the respective OATPs, (b) differences in pp type and expression levels, (c) duration of exposure and (d) metabolic (Phase I and 11) differences (Grisham eta!., 1978; Hugo-Wissemann et aI., 1991; Nyberg et aI., 1994; Stange et aI., 1995; Donato et aI., 20(8) . Most importantly, the finding of transport affinity-dependent MC toxicity was confirmed by the results obtained from exposure of primary !1Ul11an hepatocytes to single MC congeners (Fig. 7) . The primary hepatocytes of donors 1 and 2 demonstrated a higher susceptibility toward the more hydrophobic MC congeners: MCLW and MCLF appeared to be about 7 to 60 times and 7 to 39 times more toxic than the corresponding MCLR, respectively, whereas a roughly 37 to 49 times lower susceptibility toward MCRR than to MCI.R was observed.
In general, primary hlmlan hepatocytes of donors 1 and 2 appeared to be up to two orders of magnitude more susceptible to MC-induced cytotoxicity than the corresponding HEK293 OATP transfectants (Table I ) . Moreover, vast differences in MClR and -RR cytotoxicity were observed among the two donors tested. While the fonner could stem from a difference in metabolic capability between HEK293 cells and primary human hepatocytes as well as among donors (donors 1-3) of the primary hepatocytes, the latter could result from a difference in OATP expression level as well as other factors among the donors of the primary hepatocytes, despite that care was taken to ensure that all donors were female and that donors 1-3 were from the same age group. Some of these factors, beyond age and gender, are condition and metabolic capability of the respective donor's hepatocytes, i.e. largely dependent on the donor's constitution, disease history, or to metabolic alteration during culturing (Ilissell et aI., 1978; Cast ell and GomezLechon, 2009 ). Metabolic conversion, e.g. glutathione conjugation of MC, renders the MC-GSH conjugate much less toxic (Kondo et aI., 1992) . Hence, cells with lower levels of GSH-transferase or depleted of GSH will be more susceptible to MC-induced pp inhibition and thus cytotoxicity. However, given that above interpretation holds true, it would remain to be proven that the GSH conjugation of MC congeners LR, RR, LW and LF is congener dependent.
The expression levels of OATPs in primary human hepatocyres appear to vaIY within different zones of the liver. K6nig et al. (K6nig et aI., 2000b) reported stronger OATPl B3-inllmmofluorescence staining near the central vein than close to the portal vein suggesting a lobular zoning of OATP expression. Hence, the differences in MC congener susceptibility in the primary human hepatocytes observed among donors in this study could also be a reflection of differences in hepatic zonal origin introduced during liver biopsy of donors I and 2.
The direct proof of OATP-mediated uptake of MCs via use of radiolabeled substrates was not possible due to the unavailability of radiolabeled MCs. As an alternative, co-incubation studies with the known OATP substrates TC and BSP, as competitor of MCLR, were employed. These uptake competition studies should provide for indirect evidence of MC uptake into HEK293 transfectants (Fig. 6 ) and primary human hepatocytes of donor 3 (Fig. 8) , and thus support the findings of the cytotoxicity studies. Protection against MCLR-mediated cytotoxicity by co-incubation with TC and BSP could be observed in HEK293-OATPIBI and -OATPI B3, hence, providing further evidence for OATPmediated uptake of MCs. None of the applied concentrations of TC provided for protection against 5 !-lI\1. MCLR neither in primaIY human hepatocytes nor in OATP-transfected HEK293 cells. In contrast, BSP appeared to afford some protection from MCLR-mediated cytotoxicity in primary human hepatocytes (1 00 ~tl\1 BSP) and in HEK293-0ATPl Bl (lOO pM and 50 pM BSP). Notably, the lack and limited protection afforded by TC and BSP, respectively, in primaIY hlilllan hepatocytes (Fig. 8) may be explained by the fact that the primary human hepatocytes have very low levels of ser/thr PPS (Fig. 3) whereby already minute concentrations of MCLR entering the primary hepatocytes will suffice to induce cytotoxicity. The latter is also confirmed by the results of the cytotoxicity experiments ( Fig. 7; Table 1 ) demonstrating the higher susceptibility of primary human hepatocytes to MC toxicity than the corresponding IIEK293 transfectants ( Fig. 5; Table 1 ) containing higher quantities of ser/thr PPs (Fig. 3) .
Generally increased protection against MCLR cytotoxicity was observed in HEK293 OATP-transfectants when co-incubating TC and BSP with lower concentrations of MCLR Indeed, the higher the concentration ofTC, the higher the cytoprotective effect toward MCLR cytotoxicity. In contrast, 5 pM BSP provided highest protection against MCLR in HEK293-0ATPl B3 cells, while concentrations :?;50 ~tl\1 BSP appeared to be cytotoxic as well. HEK293-0ATPI B1 cells were less susceptible to BSP cytotoxicity, BSP thus affording a much higher protective effect toward MCLR cytotoxicity (Fig. 6) .
The obseIved reduced MC-mediated cytotoxicity upon co-incubation MCLR, -l.W and -LF with TC and BSP confim1s earlier findings by Feursrein et aL (2009) in primary murine whole brain cells, known to express mOatplb2, of the OATPIB family (including rat rOatplb2, human OATPl BI and OATP1B3; Hagenbuch and Meier, 2004 Dietrich et aL (2008) and Komatsu et al. (2007) . However, supporting scientific evidence has so far remained scarce. The cytotoxicity results presented in this study using HEK293 OATP-transfectants (Fig. 5) , as well as primaIY human hepatocytes (Fig. 7) thus emphasize the import;mce of toxicokinetics for understanding of the factors underlying the observed in vivo differences in toxicity among various MC congeners. Indeed, the 48 h EC so value for MCRR using OATPI B3-transfecred HEK293 cells was approximately 5-fold higher than MCLR, whereas OATPl Bl-transfected cells were resistant to MCRR cytotoxicity.ln primary human hepatocytes, the viability EC so values for MCLR and MCRR differed by a factor of 35 to 50 depending on the donor (I or 2). Distinct differences between MCL£{ and -RR toxicity have also been reported from other in vitro studies: Fastner et at. (1995) and Eriksson et al. (1990) demonstrated that primary rat hepatocytes are less sLlsceptible to MCRR (EC so 1500-4300 nM) than to MCLR (EC so 50-200 nM). Thus, irrespective of the cells used (primary hepatocytes or transfecred HEK293), MCR[{ was always 1-2 orders of magnitude less cytotoxic than MCLR. This difference in cytotoxicity compares well with the approximately I-order of magniwde difterence (Lp.
LD50 values) observed in acute mouse in vivo toxicity between MCR[{ and MCLR (Krishnamurthy et a1.. 1986; Watanabe et aI., 1988 : Lovell et aI., 1989 Stoner et aI., 1989) .
Conclusion and possible implication for present risk assessments
The results derived from the OATP-transfected HEK293 cells and the primary human hepatocytes presented here provide strong evidence that the more hydrophobic MCLW and -LF are distinctly more toxic than IIilCLR in vitro and thus potentially also in vivo. The higher toxicity of MCLF and -LW was also reported for primary murine whole brain cells (Feurstein et aI., 2(09) and for the protozoa Tetrahymena pyrifonnis (Ward and Codd, 1999) . Given that all in vitro experiments with MCR[{ and -LR provided a similar toxicity ratio as the mouse in vivo Lp. LD50 assays (Table 1) , one can assume that an in vivo mouse Lp. exposure to MCl.F and -LW would also provide for a higher toxicity of MCLF and -LW than what is reported for MCLR and -RR. As all present microcystin risk assessments and evolving guidelines values are based on data derived from in vivo exposures to MCLR, a more in-depth analysis of the risk posed by other MC congeners, e.g. MCLF and -LW, may be warranted.
Moreover, the distribution and abundance of MCLW and -LF in environmental samples have to be taken into consideration with regard to their importance for risk assessments. Unfortunately, only little informa tion exists on their occurrence in natural samples like bloom material. Azevedo et al. (1994) made the first report on MCLF isolated from a bloom of M. aeruginosa from a Brazilian water supply. Spoof et al. (2003) Ward and Codd, 1999; Metcalrand Codd. 2000) . The authors therefore consider a much more widespread occurrence of MCLW and -IF variants than previously assumed. Thus. MCLW and -I.F might pose an unknown. yet serious threat to human and animal health.
In conclusion, OATP-dependent cytotoxicity underlines the importance ofidentifying and characterizing further peptides responsible for the cell trafficking of different MC congeners using both transfected cell line models and primary cells. It must be assumed that more OATPs and most likely other membrane carriers are capable to transport MC into and out of various cell types of organisms. Indeed. to date only 4 out of 11 known human OATPs have been tested for uptake of MC, namely OATP1A2, -lB1. -lB3 and -2B1 (this study; Fischeret aI., 2005; Komatsu et aI., 2007; Monks et al.. 2007 ). Since only OATP2B1 failed in transporting MC, it appears very likely that some untested OATPs are capable of microcystin transport. Knowledge of MC congener-specific transport is crucial for the understanding of MC toxicity, including organ distribution. and hence, the improvement of human risk assessments and establishment of guideline values.
